Community-Acquired Infections/microbiology; Endocarditis, Bacterial/microbiology; Methicillin-Resistant Staphylococcus aureus/isolation & purification; Staphylococcal Infections/microbiology; Adult; Anti-Bacterial Agents/therapeutic use; Bacterial Typing Techniques; Communicable Diseases, Emerging/microbiology; Community-Acquired Infections/diagnosis; Community-Acquired Infections/drug therapy; Community-Acquired Infections/epidemiology; Endocarditis, Bacterial/diagnosis; Endocarditis, Bacterial/drug therapy; Endocarditis, Bacterial/epidemiology; Female; Gastrectomy; Genes, Bacterial; Gentamicins/therapeutic use; Humans; Lymphoma, B-Cell, Marginal Zone/radiotherapy; Lymphoma, B-Cell, Marginal Zone/surgery; Methicillin-Resistant Staphylococcus aureus/classification; Methicillin-Resistant Staphylococcus aureus/genetics; Mitral Valve Insufficiency/complications; Multiple Sclerosis/complications; Neoplasms, Second Primary/diagnosis; Ovarian Neoplasms/complications; Ovarian Neoplasms/diagnosis; Postoperative Complications/diagnosis; Postoperative Complications/drug therapy; Postoperative Complications/epidemiology; Postoperative Complications/microbiology; Rifampin/therapeutic use; Staphylococcal Infections/diagnosis; Staphylococcal Infections/drug therapy; Staphylococcal Infections/epidemiology; Stomach Neoplasms/radiotherapy; Stomach Neoplasms/surgery; Vancomycin/therapeutic use

CA-MRSA; CMI oxacilline; Endocardite infectieuse; Infective endocarditis; Oxacillin MIC; S. aureus; SARM communautaire; TSST-1